DAWN - Day One Biopharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$21.50
DETAILS
HIGH:
$21.50
LOW:
$21.50
MEDIAN:
$21.50
CONSENSUS:
$21.50
DOWNSIDE:
0.14%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 89.1% |
| EBIT Margin | -80.8% |
| EBITDA Margin | -78.4% |
| Operating Margin | -80.8% |
| Pretax Margin | -69.1% |
| Cont. Ops Margin | -67.8% |
| Net Margin | -67.8% |
| Bottom Line Margin | -67.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 8.02 |
| Quick Ratio | 7.91 |
| Solvency Ratio | -1.553 |
| Cash Ratio | 3.26 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-8.98
Peers avg: 15.2
|
| PEG Ratio | -4.58 |
| Forward PEG | -4.58 |
| Price/Book | 2.18 |
| Price/Sales | 6.09 |
| Price/FCF | -9.26 |
| Price/Op Cash Flow | -9.29 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0055 |
| Debt/Equity | 0.0063 |
| Debt/Capital | 0.0063 |
| Long-Term Debt/Capital | 0.0059 |
| Financial Leverage | 1.15 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.35 |
| Operating Cash Flow Ratio | -1.714 |
| Operating Cash Flow/Sales | -65.6% |
| Free Cash Flow/Operating Cash Flow | 100.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -701.08 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -596.30 |
| Operating Cash Flow Coverage | -37.15 |
| Capital Expenditure Coverage | -324.24 |
| Dividend + Capital Expenditure Coverage | -324.24 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.53 |
| EPS | -1.038 |
| Debt/Share | 0.0270 |
| Cash/Share | 4.27 |
| Book Value/Share | 4.27 |
| Tangible BV/Share | 4.09 |
| Equity/Share | 4.27 |
| Operating Cash Flow/Share | -1.004 |
| Capital Expenditure/Share | 0.003 |
| FCF/Share | -1.007 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.982 |
| Earnings Before Tax/EBIT | 0.856 |
| Price/Fair Value | 2.18 |
| Debt/Market Cap | 0.0029 |
| Effective Tax Rate | 1.8% |
| Enterprise Value Multiple | -6.21 |